Evidence-informed Depo-Provera review

Depo-Provera campaign information and records checklist

This campaign focuses on reported Depo-Provera or generic injectable medroxyprogesterone acetate use and a later intracranial meningioma diagnosis. Intake reviewers use product, timing, and medical records to understand each submission.

Start your private review Review campaign information

Depo-Provera Lawsuits

Depo-Provera is a popular contraceptive shot that has been linked to severe side effects, including bone density loss and an increased risk of breast cancer. Many lawsuits allege that the manufacturer failed to properly warn users about the long-term risks of using Depo-Provera.

Depo-Provera Lawsuit Facts

Depo-Provera is a hormonal contraceptive injection that prevents pregnancy for up to three months.

Common side effects include weight gain, irregular bleeding, bone density loss, and increased risk of breast cancer.

Yes, if you have experienced severe side effects or health complications after using Depo-Provera, you may be eligible to file a lawsuit.

Contact a lawyer experienced in pharmaceutical lawsuits for a consultation and guidance on your specific case.

Compensation varies based on individual circumstances, including medical expenses, lost wages, and pain and suffering.

Who Is Eligible to File a Depo-Provera Lawsuit?

You may be eligible to file a Depo-Provera lawsuit if:

You received Depo-Provera injections as a form of birth control.
You were later diagnosed with a brain tumor (such as meningioma or another hormone-related tumor).
You were not properly warned about the potential risk of developing a brain tumor.

Individuals who have experienced serious side effects or developed health conditions after using Depo-Provera may qualify for compensation through a lawsuit.

People who have used Depo-Provera and faced severe health complications can take legal action against the manufacturer for negligence.

Did you suffer side effects after using Depo-Provera?

Free Case Review

A lawsuit may help you seek compensation for medical bills, lost wages, and emotional distress.

Case Review Form

First Name*

Last Name*

Email*

Phone*

Zip code*

Have you used Depo-Provera for birth control?*

Yes

After starting Depo-Provero, did you experience any of the following?*

Please Select One

Have you been diagnosed with meningiomas (brain or spinal cord tumors)?*

Yes

Other Helpful Details (Optional):

In order to be most prepared to speak to you, please describe your situation and legal needs.

By checking this box and submitting my request, I agree to the Terms & Conditions, Privacy Policy, and Cookies Policy. You also give TCPA consent to this site and consent to receive emails, phone calls, and/or text message offers and communications from AMMS and its network of participating lawyers working in this area of practice at any telephone number or email address provided by me. I understand there may be a charge by my wireless carrier for such communications. I understand these communications may be generated using an auto-dialer and may contain pre-recorded messages, and that consent is not required to utilize such services.

Evidence-informed Depo-Provera review

Campaign guidance, records, and sources

Review the supporting information below before or after completing the private campaign form.

Go to this campaign form Sources and records

Evidence5 referenced sources

Official and authoritative background links used for intake education.

Prepare5 record categories

A practical checklist to help organize useful details before review.

Reviewed09/15/2026

Reviewed for intake accuracy by AMMS Compliance Team

Records and details that may help

Prescription, injection, pharmacy, or provider records identifying the product and manufacturer when available
Approximate first and last injection dates and total length of use
Meningioma diagnosis records, imaging reports, pathology, and treatment timeline
Names of prescribing providers, treatment facilities, and pharmacies
Other hormone treatment history or medical details a reviewer may need to understand

Sources used for intake education

These official references are provided for background education only. They do not replace medical or legal advice.

FDA 2025 Depo-Provera prescribing informationThe current FDA label describes a possible increased risk for growth of a meningioma, primarily with long-term use.
FDA supplemental approval letterFDA approval record for adding meningioma information to warnings, counseling information, and patient materials.
Federal court Depo-Provera MDL No. 3140Official Northern District of Florida page for the coordinated federal product-liability proceedings and current court documents.
JPML transfer order for MDL No. 3140The Judicial Panel centralized the federal actions on February 7, 2025. The order summarizes the allegations and contested questions.
European Medicines Agency safety reviewEMA safety review describing the meningioma signal for high-dose medroxyprogesterone, especially after prolonged use.

1. Submit the intake form

Share your contact details and answer the existing campaign-specific questions.

2. Organize supporting details

Gather the records, dates, communications, and other details listed for this campaign.

3. Intake follow-up

AMMS or an authorized intake partner may contact you for missing or clarifying details.

4. Legal review if appropriate

Qualified legal professionals decide whether a claim can move forward. AMMS does not provide legal advice or guarantee results.

Frequently asked questions

What is the current status of the Depo-Provera litigation?

Federal product-liability cases involving alleged meningioma injuries are coordinated in MDL No. 3140 in the Northern District of Florida for pretrial proceedings. Centralization does not decide whether the allegations are true or whether any individual claim qualifies.

What Depo-Provera records are helpful for intake?

Injection records, pharmacy records, prescribing-provider details, diagnosis records, imaging reports, and treatment timelines are useful for intake review.

Does the FDA label mention meningioma?

Yes. FDA-approved labeling updated in 2025 describes a possible increased risk for growth of a meningioma, primarily when the product is used for a long time. A label warning does not establish eligibility or causation for an individual claim.

Can AMMS tell me whether my medical condition was caused by Depo-Provera?

No. AMMS does not provide medical or legal causation opinions. Qualified medical and legal professionals evaluate those questions.

Related AMMS resources

AMMS Legal Intake Research TeamReviewed for intake accuracy by AMMS Compliance TeamLast reviewed: 09/15/2026

Important: AMMS provides intake and educational information. We are not providing medical or legal advice on this page, and submitting a form does not create an attorney-client relationship. Case value, eligibility, filing deadlines, and legal strategy must be reviewed by qualified professionals.